MedPath

Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer

Completed
Conditions
Bladder Cancer Recurrence
Registration Number
NCT00903240
Lead Sponsor
Predictive Biosciences
Brief Summary

The purpose of this study is to detect recurrent bladder cancer using a combination of protein and DNA biomarkers in urine

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Intact bladder
  • Scheduled for cystoscopy for transitional cell bladder cancer recurrence screening
  • Urine donated prior to cystoscopy, Bladder biopsy, chemotherapy, intravesical therapy, radiation or TUR
  • Must be willing to sign IRB approved informed consent
Exclusion Criteria
  • History or current diagnosis of any cancer except transitional cell bladder cancer or basal cell cancer
  • Known diagnosis of any autoimmune disease or HIV, HCV or HBV
  • History or current TB or any other active infection
  • Subject has gross hematuria
  • Receiving chemotherapy, intravesical therapy or radiation within 30 days of enrollment
  • Any surgery except urologic within past 30 days

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (20)

BCG Oncology

🇺🇸

Phoenix, Arizona, United States

Urology Associates

🇺🇸

Engelwood, Colorado, United States

Atlantic Urological Associates

🇺🇸

Daytona Beach, Florida, United States

Winter Park Urology

🇺🇸

Orlando, Florida, United States

Metropolitan Urology

🇺🇸

Jeffersonville, Indiana, United States

Mayo Validation Support Services

🇺🇸

Rochester, Minnesota, United States

Metro Urology

🇺🇸

Woodbury, Minnesota, United States

Associates in Urology/Urology Group of NJ

🇺🇸

741 Northfield Avenue, New Jersey, United States

Coastal Urology Associates

🇺🇸

Brick, New Jersey, United States

Capital Regional Urological Surgeons

🇺🇸

Albany, New York, United States

Scroll for more (10 remaining)
BCG Oncology
🇺🇸Phoenix, Arizona, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.